Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in certain receptors can cause diseases and offer new treatment options.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Early balding at 40 increases prostate cancer risk.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Larger prostate size in older men may be linked to poorer semen quality and fertility issues.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Male skin gets drier and more alkaline as it ages, which may need different skincare than women's skin.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Large prostate links to more hair loss, but age of onset doesn't affect it.

Suppressing certain hormones might help prevent prostate cancer.